Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 :
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 : report together with additional views (to accompany H.R. 5333) (including cost estimate of the Congressional Budget Office).
Over the Counter Monograph Safety, Innovation, and Reform Act of 2018 : report together with additional views (to accompany H.R. 5333) (including cost estimate of the Congressional Budget Office)
- 95 pages ; 24 cm.
- Report / 115th Congress, 2d session, House of Representatives ; 115-827 .
- United States. Congress. House. Report ; 115-827. .
"July 16, 2018." Shipping list no.: 2018-0224-M. CRDP Program record.
Microfiche.
[Washington, D.C.] :
U.S. Government Printing Office,
[2018]
1 microfiche : negative.
United States. Food and Drug Administration --Rules and practice.
United States. Federal Food, Drug, and Cosmetic Act.
United States. Food and Drug Administration.
Federal Food, Drug, and Cosmetic Act (United States)
Drugs, Nonprescription--Law and legislation--United States.
Pharmaceutical policy--United States.
Drugs--Law and legislation--Compliance costs--United States.
Nonprescription drug industry--State supervision--United States.
Drugs, Nonprescription--Law and legislation.
Pharmaceutical policy.
United States.
Legislative materials.
Legislative materials.
Rules.
KF32 / .E55 2018zo
1008-D (MF)
Y 1.1/8:115-827
"July 16, 2018." Shipping list no.: 2018-0224-M. CRDP Program record.
Microfiche.
[Washington, D.C.] :
U.S. Government Printing Office,
[2018]
1 microfiche : negative.
United States. Food and Drug Administration --Rules and practice.
United States. Federal Food, Drug, and Cosmetic Act.
United States. Food and Drug Administration.
Federal Food, Drug, and Cosmetic Act (United States)
Drugs, Nonprescription--Law and legislation--United States.
Pharmaceutical policy--United States.
Drugs--Law and legislation--Compliance costs--United States.
Nonprescription drug industry--State supervision--United States.
Drugs, Nonprescription--Law and legislation.
Pharmaceutical policy.
United States.
Legislative materials.
Legislative materials.
Rules.
KF32 / .E55 2018zo
1008-D (MF)
Y 1.1/8:115-827